Kamakura, Japan

Manami Ohnuma


Average Co-Inventor Count = 4.4

ph-index = 4

Forward Citations = 66(Granted Patents)


Location History:

  • Kanagawa, JP (1996)
  • Yokohama, JP (1997)
  • Kamakura, JP (2000 - 2002)

Company Filing History:


Years Active: 1996-2002

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Manami Ohnuma: Innovator in Vasodilating Action Research

Introduction

Manami Ohnuma is a prominent inventor based in Kamakura, Japan. She has made significant contributions to the field of pharmacology, particularly in the study of vasodilating actions. With a total of 4 patents, her work has garnered attention for its innovative approaches and applications.

Latest Patents

Ohnuma's latest patents include a method for screening agonists or antagonists of the maxadilan receptor, which plays a crucial role in vasodilating action. This method utilizes a receptor of maxadilan, compounds that specifically bind to the receptor, and a tissue preparation containing the receptor. The compounds she has developed are variants of maxadilan derived from the salivary glands of the sand fly. Additionally, she has worked on peptides that have a specific affinity to pituitary adenylate cyclase activating polypeptide (PACAP) receptors. Notably, her research identifies MAX and NSP as agonists to PACAP type 1 receptors, while M65 acts as an antagonist.

Career Highlights

Throughout her career, Ohnuma has been associated with notable organizations, including Shiseido Company, Limited and The General Hospital Corporation. Her work in these institutions has allowed her to advance her research and contribute to the scientific community.

Collaborations

Ohnuma has collaborated with esteemed colleagues such as Masahiro Tajima and Osamu Moro. These partnerships have enriched her research and expanded the impact of her innovations.

Conclusion

Manami Ohnuma's contributions to the field of pharmacology, particularly in the area of vasodilating actions, highlight her role as an influential inventor. Her innovative methods and collaborations continue to shape the landscape of medical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…